- Home
- RLAY vs CCEC Comparison
RLAY vs CCEC Comparison
Compare RLAY & CCEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RLAY | CCEC |
|---|---|---|
| Founded | 2015 | 2007 |
| Country | United States | Greece |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.3B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | RLAY | CCEC |
|---|---|---|
| Price | $14.96 | $18.00 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 2 |
| Target Price | $17.38 | ★ $25.50 |
| AVG Volume (30 Days) | ★ 2.8M | 5.0K |
| Earning Date | 05-04-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 3.46% |
| EPS Growth | ★ 31.78 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $15,355,000.00 | N/A |
| Revenue This Year | N/A | $18.95 |
| Revenue Next Year | $324.03 | $43.14 |
| P/E Ratio | ★ N/A | $4.82 |
| Revenue Growth | ★ 53.44 | N/A |
| 52 Week Low | $2.30 | $14.83 |
| 52 Week High | $15.00 | $24.83 |
Technical Indicators
Market Signals| Indicator | RLAY | CCEC |
|---|---|---|
| Relative Strength Index (RSI) | 80.08 | 32.47 |
| Support Level | $6.42 | N/A |
| Resistance Level | N/A | $21.80 |
| Average True Range (ATR) | 0.86 | 0.91 |
| MACD | 0.52 | -0.18 |
| Stochastic Oscillator | 92.28 | 22.08 |
Price Performance
Historical ComparisonAbout RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About CCEC Capital Clean Energy Carriers Corp.
Capital Clean Energy Carriers Corp is an international shipping company. It is the platform of gas carriage solutions with a focus on the energy transition. The company owns 20 high-specification vessels, including 12 latest-generation LNG carriers (LNG/Cs) and eight legacy Neo-Panamax container vessels.